SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a - 16 OR 15d - 16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of January, 2003
SkyePharma PLC, 105 Piccadilly, London W1J 7NJ England
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______
For Immediate Release 15 January 2003 SkyePharma Plc Notification of Major Interest in Shares In accordance with Sections 198-203 of the Companies Act 1985 the Company was informed today that Dr Jacques Gonella has disposed of 5,030,000 Ordinary Shares of 10 pence each. Dr Gonella holding now stands at 53,676,779 Ordinary Shares of 10 pence each, representing 8.75% of the issued share capital of the Company. Dr Gonella made the following comment in his notification:- 'I would like to point out that the present sale purely relates to private and personal reasons. I remain fully confident in SkyePharma's performances and future success.' - e n d s - END
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
By: /s/ Douglas Parkhill
Name: Douglas Parkhill
Title: Company Secretary
Date: January 15, 2003